Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
81.5M
-
Shares change
-
+2.85M
-
Total reported value, excl. options
-
$4.04B
-
Value change
-
+$66M
-
Put/Call ratio
-
1.79
-
Number of buys
-
183
-
Number of sells
-
-154
-
Price
-
$49.57
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q4 2018
418 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q4 2018.
Teladoc Health, Inc. - Common Stock (TDOC) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.5M shares
of 175M outstanding shares and own 46.45% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.8M shares), Vanguard Group Inc (6.07M shares), JPMORGAN CHASE & CO (5.34M shares), FMR LLC (5.2M shares), WELLINGTON MANAGEMENT GROUP LLP (4.07M shares), ALLIANCEBERNSTEIN L.P. (2.6M shares), BANK OF AMERICA CORP /DE/ (2.04M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.71M shares), ZEVENBERGEN CAPITAL INVESTMENTS LLC (1.7M shares), and JANUS HENDERSON GROUP PLC (1.6M shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.